Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
Ayurvedic
By Brand Name
By Generic Name
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Material Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
The Principles of Disclosure of MI & PSI
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
Ayurvedic
By Brand Name
By Generic Name
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
Quality Operations
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Material Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
The Principles of Disclosure of MI & PSI
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Financial Reports
Annual Report
1st Quarter
2nd Quarter
3rd Quarter
Annual Report 2023-2024
Read More
Annual Report 2022-2023
Read More
Annual Report 2021-2022
Read More
Annual Report 2020-2021
Read More
Annual Report 2019-2020
Read More
Annual-Report-2018-2019
Read More
Annual-Report-2017-2018
Read More
Annual-Report-2016-2017
Read More
Annual-Report-2015-2016
Read More
Annual-Report-2014-2015
Read More
Annual-Report-2013-2014
Read More
1st Quarter-2024-2025
Read More
1st Quarter-2023-2024
Read More
1st Quarter-2022-2023
Read More
1st Quarter-2021-2022
Read More
1st Quarter-2020-2021
Read More
1st Quarter-2019-2020
Read More
1st Quarter-2018-2019
Read More
1st Quarter-2017-2018
Read More
1st Quarter-2016-2017
Read More
2nd Quarter 2023-2024
Read More
2nd Quarter 2022-2023
Read More
2nd Quarter 2021-2022
Read More
2nd Quarter-2020-2021
Read More
2nd Quarter-2019-2020
Read More
2nd Quarter-2018-2019
Read More
2nd Quarter-2017-2018
Read More
2nd Quarter-2016-2017
Read More
3rd Quarter-2015-2016
Read More
3rd Quarter-2016-2017
Read More
3rd Quarter-2017-2018
Read More
3rd Quarter-2018-2019
Read More
3rd Quarter-2019-2020
Read More
3rd Quarter-2020-2021
Read More
3rd Quarter-2021-2022
Read More
3rd Quarter 2022-2023
Read More
3rd Quarter 2023-2024
Read More